Huntsman (HUN)
(Delayed Data from NYSE)
$25.18 USD
+0.27 (1.08%)
Updated May 17, 2024 04:00 PM ET
After-Market: $25.19 +0.01 (0.04%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth F Momentum F VGM
Brokerage Reports
Huntsman Corporation [HUN]
Reports for Purchase
Showing records 81 - 100 ( 461 total )
Company: Huntsman Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
Company: Huntsman Corporation
Industry: Chemical - Diversified
Company: Huntsman Corporation
Industry: Chemical - Diversified
1Q22 First Look - Sizable Beat in 1Q; Strong 2Q Guide
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
1Q22 Follow Up - Current Trends Remain Strong; Management Acknowledges Uncertainty
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
Company: Huntsman Corporation
Industry: Chemical - Diversified
Chemicals: 1Q22 Preview - Demand Is at Cycle Peak, but Some Commodities Could Work, We Believe
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
Company: Huntsman Corporation
Industry: Chemical - Diversified
Following Up on Board Results and New Share Repurchase Program
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
Chemicals: Takeaways from IHS''s World Petrochemical Conference
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
Company: Huntsman Corporation
Industry: Chemical - Diversified
We See More Balanced Risk/Reward in Near Term
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
Company: Huntsman Corporation
Industry: Chemical - Diversified
4Q21 First Look - Strong All-Around Guide and Results
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
4Q21 Follow Up - Outlook Remains Contructive; Raise PT to $48
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department